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transmembrane Notch receptor after binding to its transmem-
brane ligands, Delta or Jagged; and the resultant soluble intra-
cellular domain of Notch stimulates a cascade of transcriptional
events. The Delta1 ligand also undergoes proteolytic cleavage
upon Notch binding, resulting in the production of a free intra-
cellular domain. We demonstrate that the expression of the
intracellular domain of Delta1 results in a non-proliferating
senescent-like cell phenotype which is dependent on the expres-
sion of the cell cycle inhibitor, p21, and is abolished by co-
expression of constitutively active Notch1. These data suggest
a new intracellular role for Delta1.
 2005 Published by Elsevier B.V. on behalf of the Federation of
European Biochemical Societies.
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The Notch signaling pathway plays a critical role in cell fate
determination at all stages of organism development [1]. The
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direct interaction with transmembrane ligands expressed on
the surface of neighboring cells. This interaction results in con-
secutive cleavages of Notch by an ADAMmetalloprotease and
by a presenilin-dependent c-secretase. The generated Notch
intracellular domain (icd) translocates into the nucleus where
it interacts with the transcription factors of the CSL family
or activates CSL-independent signaling pathway(s) (for review
see [2]).
We have demonstrated that the expression of the soluble
extracellular domain of Delta1 (sDl1) enhances cell prolifera-
tion, and induces the non-classical release of FGF1 [3]. Re-
cently Notch-dependent proteolytic cleavage was reported
for Drosophila and mammalian Notch ligands of the Delta
family [4–6]. Upon interaction with Notch, Delta is cleaved
by an ADAM metalloprotease and presenilin/c-secretase that
release Delta icd from the plasma membrane. Immunohisto-
chemistry experiments demonstrate that Drosophila Delta icd
is able to enter the nucleus [5]. Interestingly, the icd of mam-
malian Delta1 (Dl1icd) contains a PDZ-binding site [7,8].
The ability of Delta to undergo proteolytic cleavage of its icd
suggests a bidirectional character of Notch signaling. In the
present study, we investigated the biological eﬀects of Dl1icd
expression in cell cultures. We demonstrate that Dl1icd in-
duced p21-dependent blockage of DNA synthesis and cell pro-
liferation arrest. Interestingly, constitutively active Notch1
(N1icd) was able to reverse Dl1icd1- induced phenotype.2. Materials and methods
2.1. Cell cultures
Human umbilical vein endothelial cells (HUVEC) (ATCC) at pas-
sages 7–12 were grown in EBM medium supplemented with EGM-2
growth factor cocktail (Cambrex). NIH 3T3 murine ﬁbroblasts
(ATCC), HEK293 cells (ATCC), p21/, p27/ and wt mouse em-
bryo ﬁbroblasts (MEF) (gift of Dr. C. Sherr, St. Jude Childrens Re-
search Hospital in Memphis, Tennessee) were grown in Dulbeccos
modiﬁed Eagles medium (DMEM; Life Technologies) supplemented
with 10% fetal bovine serum (Hyclone).
2.2. DNA constructs, transfection, preparation of adenoviruses and
adenoviral transduction
To study the biological role of human Dl1icd, nucleotide sequence
coding for amino acids 569–723 was cloned in pcDNA 3.1-Zeo vec-
tor (Invitrogen) in restriction sites XbaI and HindIII. Additionally,ation of European Biochemical Societies.
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cells were transfected using FuGene (Roche) transfection reagent
according to the manufacturers instructions. Selection of stably
transfected NIH 3T3 cells was described earlier [9]. Dl1icd was also
cloned in the multiple cloning site of the pAdlox shuttle vector
(Invitrogen). The corresponding adenoviruses were prepared as de-
scribed [10], and used to transduce HUVEC and MEF. In a series
of experiments, an adenoviral construct expressing human N1icd
[10] was used to transduce HUVEC 16–24 h before Dl1icd transduc-
tion. The control LacZ adenoviral construct was described earlier
[10]. Alternatively, the control pcDNA3.1() Myc-His/LacZ con-
struct (Invitrogen) was used for transient transfection. Full length
human Delta 1 (ﬂDl1) used for transient transfection was cloned
into the EcoR1 and Bam H1 sites of the plasmid pcDNA3.1A
() Myc-His (Invitrogen) [11]. The eﬃciency of Dl1icd and N1icd
transduction was controlled using immunoﬂuorescence anti-V5 stain-
ing, and it was always above 90%.
2.3. Site-directed mutagenesis
To mutate the nuclear localization sequences (NLS) of Dl1icd, we
used a PCR-based strategy. Mutations were introduced with following
primers: Dl1icd-nls1 – (s) cagaagcacgccccagccgacccctg and ggacggct-
ggggcgtgcttctgcagcc (as); Dl1icd-nls2 – (s) gaagcatctgaacaaaggccggac-
tcgggctgttc and (as) cagccgagtccggcctttgttcagatgcttctccaccc, using a
Stratagene site-directed mutagenesis kit following the manufacturers
instructions. PDZ-binding site deletion mutant was generated by intro-
ducing a stop codon at amino acid 720 by using the following primers:
(s) gatgagtgcgtctgagcaactgaggtftaa and (as) cacctcagttgctcagacgcactc-
atccttctc.
2.4. Immunoblot analysis
Lysates of LacZ- and Dllicd-transduced HUVEC were prepared, re-
solved by 12% or 15% SDS–PAGE and immunoblotted as described
previously [12] using either a mouse anti-p21 (BD Biosciences), mouse
anti-p27 (BD Biosciences), rabbit anti-cyclin A (Santa Cruz), rabbit
anti-cyclin E (BD Biosciences), rabbit anti-cyclin D1 (Santa Cruz),
rabbit anti-b-actin (Sigma) or rabbit anti-pErk1/2 antibodies (Cell Sig-
naling).
2.5. Immunoﬂuorescence confocal microscopy
Cells growing on glass coverslips were ﬁxed 24 h after Dl1icd of
ﬂDl1 transfection with 4% (w/v) paraformaldehyde. Anti-V5 (Invitro-
gen) or anti-Myc (Covance) antibodies followed by FITC-conjugated
secondary antibody were used to visualize, respectively, Dl1icd or
ﬂDl1. TO-PRO3 (Molecular Probes) was used to stain DNA as de-
scribed previously [13]. Immunoﬂuorescently stained cells were ana-
lyzed using a TC-SP confocal microscope (Leica).
2.6. DNA synthesis assay
[3H]-Thymidine autoradiography was used to evaluate the levels of
DNA synthesis as described previously [13]. The percentage of 3H-la-
beled nuclei was calculated using an inverted Olympus microscope. In
experiments with transient transfection, transfected cells were identi-
ﬁed by immunoperoxidase staining as described [14] using antibodies
against V5 or against b-galactosidase.
2.7. Acidic b-galactosidase staining
Cells transduced with Dl1icd were washed in PBS, ﬁxed for 5 min in
2% formaldehyde/0.2% glutaraldehyde, washed, and stained for acidic
b-galactosidase as described [15].
2.8. Real time RT-PCR
Total RNA from LacZ- and Dl1icd-transduced HUVEC was iso-
lated using RNAeasy (Qiagen) according to the manufacturers proto-
col. cDNA was obtained from 5 lg of total RNA with SuperScripte
(Invitrogen) reverse transcriptase by using an oligo(dT) primer (Invit-
rogen). Real-time PCR was performed using the Icycler IQ Real-Time
PCR (Bio-Rad) according to the manufacturers recommendations.
Ampliﬁcation of the gapdh cDNA was used as the endogenous normal-
ization standard. Each sample was ampliﬁed in triplicate. The follow-
ing speciﬁc primers were used for RT-PCR analysis of p21: (s)
gattagcagcggaacaagga, (as) caactactcccagccccata.3. Results
To study the biological eﬀects of Dl1icd in cell culture, we
transfected NIH 3T3 cells for further selection of cells stably
expressing Dl1icd. Surprisingly, unlike sDl1 transfectants [3],
cells transfected with Dl1icd failed to form colonies. Instead,
Dl1icd transfectants surviving selection assumed morphology
reminiscent of senescent ﬁbroblasts: large, well-spread cells
with hypertrophic cytoplasm (Fig. 1A). Since clones of stable
Dl1icd transfectants did not arise, we prepared an adenoviral
construct for Dl1icd expression, which allowed us to eﬃciently
express Dl1icd in non-immortalized cells, such as HUVEC.
To assess the ability of Dl1icd to inhibit DNA synthesis in
HUVEC, Dl1icd- and control LacZ-transduced HUVEC were
labeled with [3H]-thymidine 48 h after transduction for a peri-
od of 16 h. The expression of Dl1icd resulted in the dramatic
inhibition of DNA synthesis (Fig. 1B). Similar results were ob-
tained with NIH 3T3 (data not shown) or HEK293 cell trans-
duced with Dl1icd (Fig. 1F).
To further evaluate the status of Dl1icd-transduced HU-
VEC, we assessed the expression of b-galactosidase active
at pH 6, a common biomarker of senescent non-immortal-
ized cells [15]. Dl1icd transduction induced the activity of
acidic b-galactosidase in HUVEC after 2 days, and most of
the cells were acidic b-galactosidase positive after 4 days
(Fig. 1C). The growth of Dl1icd-transduced HUVEC
stopped, and cells remained viable and non-proliferating
for at least 2 months (data not shown). Since cell senescence
in vitro is normally accompanied by the reduction of telo-
mere length [16], we assessed this parameter by using the
Telomere Length Assay kit (Roche). Interestingly, no signif-
icant diﬀerence in telomere length was observed between
Dl1icd- and LacZ-transduced cells 4 days after transduction
(data not shown).
Recent studies demonstrated nuclear localization of Dro-
sophila Delta icd [5]. To evaluate the ability of mammalian
Dl1icd to localize into the nucleus, we transiently transfected
HEK293 cells with C-terminally Myc-tagged human ﬂDl1
and N-terminally V5-tagged Dl1icd. Confocal microscopy
analysis, using the anti-Myc antibody, demonstrated cytoplas-
mic distribution of ﬂDl1 (Fig. 1E). Conversely, Dl1icd was
found both in the nuclei and cytoplasm of transfected cells
(Fig. 1E). Analysis of the amino acid sequence of Dl1icd re-
veals two potential NLS domains – 575KHRPP579 and
689RKRPP692 (Fig. 1D). To investigate the functionality of
Dl1icd NLS and their importance for Dl1icd biological eﬀect,
we prepared a series of mutants: in Dl1icd-nls1, amino acids
575KHRPP579 were mutated to KHAP; and in Dl1icd-nls2,
amino acids 689RKRPP692 were mutated to RQP. In Dl1icd-
nlsDM (double mutant), both hypothetical NLS in Delta1
were mutated as described above. While both Dl1icd-nls1
and Dl1icd-nls2 exhibited nuclear and cytoplasmic localization
similarly to wild type Dl1icd, Dl1icd-nlsDM was detected
exclusively in the cytoplasm of transfected cells (Fig. 1E).
The autoradiographic studies of DNA synthesis in transiently
transfected HEK293 cells demonstrated that when one or both
of the Deltas NLS were mutated, the percentage of labeled nu-
clei was similar to that in the cells transduced with wild type
Dl1icd, i.e., 3 times lower than in cells transfected with LacZ
(Fig. 1F). In a similar series of experiments, we assessed the
role of the C-terminal PDZ-binding domain of Dl1icd in its
antiproliferative eﬀect. We produced a deletion mutant of
Fig. 1. Cells expressing Dl1icd adopt a senescent-like phenotype. (A) Cell morphology. Dl1icd-transfected NIH 3T3 cells 4 days after transfection
and zeocin selection (phase contrast). (B) DNA synthesis. HUVEC were labeled for 16 h with 1 lCi/ml [3H]-thymidine starting at 48 h after
transduction with Dl1icd or LacZ. Bars represent average percentage of 3H-labeled nuclei in LacZ- and Dl1icd-transduced HUVEC ± standard
deviation (S.D.). (C) Acidic b-galactosidase expression. HUVEC adenovirally transduced with Dl1icd stained for acidic b-galactosidase 4 days after
transduction. (D) Scheme of Dl1icd structure showing NLS and the PDZ-binding domain. (E) Nuclear localization of Dl1icd and its NLS mutants.
HEK293 cells were transiently transfected either with ﬂDl1, Dl1icd, or its corresponding NLS mutants as indicated. Cells were ﬁxed, immunostained
with anti-V5 antibody (Dl1icd and derived NLS mutants), or anti-Myc antibody (ﬂDl1), and co-stained with TO-PRO3 48 h after transfection, and
studied using confocal microscopy as described earlier [13]. (F) DNA synthesis. HEK293 were transiently transfected with LacZ, Dl1icd or Dl1icd-
NLS mutants. DNA synthesis after transfection was determined using [3H]-thymidine incorporation as described in Section 2. The average
percentage of labeled nuclei ± S.D. is represented.
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(721TEV723), and found that it induces the inhibition of
DNA synthesis similarly to the wild type Dl1icd (data not
shown). Thus, nuclear localization is not required for the anti-
proliferative activity of Dl1icd, and PDZ-binding domain is
dispensable for this eﬀect. It can be hypothesized that PDZ-
binding site is instead relevant to the interaction of transmem-
brane ﬂDl1 with its cytoplasmic partners. The particular re-
gion(s) of Dl1icd required for the inhibition of cell
proliferation remains to be elucidated.
Progression through the cell cycle is controlled by a group of
cyclin-dependent kinases (cdks) and their inhibitory proteins
[17]. Therefore, we assayed the expression of the cdk inhibi-
tors, p21 and p27, in Dl1icd expressing cells. Western blot
analysis revealed signiﬁcant induction of p21 and p27 expres-
sion in HUVEC transduced with Dl1icd (Fig. 2A). At the same
time, the expression of cyclins D1, A, and E as well as the lev-
els of phosphorylated Erk 1 and Erk 2 in Dl1icd-transduced
cells were not signiﬁcantly changed (data not shown). We
hypothesized that Dl1icd may induce growth arrest throughupregulation of p21 or p27 expression or both. To assess this
hypothesis, we utilized p21/ and p27/ MEF. Similarly
to wild type (wt) MEF, Dl1icd transduction resulted in
DNA replication blockage in p27 knockout MEF but the
p21 knockout MEF were refractory to the inhibitory eﬀect
of Dl1icd (Fig. 2B). To further elucidate the stage of expres-
sion at which Dl1icd regulates p21 levels, we performed quan-
titative RT-PCR analysis and p21 promoter assay. We
demonstrated that Dl1icd expression resulted in a strong in-
crease of both p21 promoter activity in HEK293 cells (data
not shown) and p21 mRNA levels in HUVEC (Fig. 2C).
Notch signaling determines the fate of many cell types
through regulation of cell proliferation, diﬀerentiation, and
apoptosis [1]. Since the expression of Notch1 overlaps the
expression patterns of its ligands, Delta1 and Jagged1 [18–20],
and since ligand-activated Notch cleavage results in the produc-
tion of the soluble intracellular fragment of Notch, we sought to
determine whether N1icd interferes with the biological eﬀects of
Dl1icd. To this end, we transduced HUVECwith N1icd-adeno-
virus 16 h prior to Dl1icd adenoviral transduction. Expression
Fig. 2. Dl1icd-induced proliferation blockage is p21-dependent. (A)
Dl1icd- and LacZ-transduced HUVEC were harvested 48 h after
adenoviral transduction. Cell lysates were resolved by 15% SDS–
PAGE and immunoblotted for cdk inhibitors, p21 and p27. Immu-
noblot for b-actin served as control of equal protein loading. (B) DNA
synthesis in p21 and p27 knockout MEF expressing Dl1icd. p21/,
p27/, and control wt MEF were labeled for 16 h with 1 lCi/ml [3H]-
thymidine starting at 48 h after transduction with Dl1icd. Bars
represent average percentage of 3H-labeled nuclei ± S.D. (C) Dl1icd
induced expression of p21 mRNA in HUVEC. The expression of p21
was assessed by real time RT-PCR using the primers and conditions
described in Section 2. The bars represent p21 mRNA levels
normalized to gapdh mRNA levels ± S.D.
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type, as it was manifested by prevention of the expression of
acidic b-galactosidase and of DNA synthesis blockageFig. 3. N1icd expression prevents the eﬀects of Dl1icd. (A) Dl1icd-induced
LacZ, and 16 h later, the second transduction with Dl1icd or LacZ was per
second transduction [13]. The average percentages of [3H]-thymidine-labeled
activity. HUVEC were transduced with N1icd or LacZ; and 16 h later, cells
stained for acidic b-galactosidase 4 days after the second transduction. (C) p2
later, cells were additionally transduced with either Dl1icd or LacZ. 48 h
immunoblotted for p21. Immunoblot for b-actin served as control of equal(Fig. 3B and A). Also, N1icd expression abrogated the induc-
tion of p21 expression by Dl1icd (Fig. 3C).4. Discussion
We found that Dl1icd induced a p21-dependent inhibition of
cell proliferation. Under the same experimental conditions the
artiﬁcial expression of both LacZ and N1icd failed to inhibit
DNA synthesis and, moreover, N1icd speciﬁcally abrogated
the eﬀect of Dl1icd, demonstrating that the antiproliferative
activity of Dl1icd was not due to its overexpression. The irrel-
evance of nuclear localization of Dl1icd for its anti-proliferative
eﬀect indicated that Dl1icd does not participate directly in the
activation of p21 transcription. This eﬀect is most probably
mediated through a cytoplasmic signaling pathway. Interest-
ingly, HUVEC express Notch1, Delta1, and glycosyltransferase
Lunatic Fringe (LFng) (data not shown). LFng potentiates the
interaction between Notch1 and Delta1 [21]. The ability of
HUVEC to proliferate may be maintained due to the simulta-
neous production of N1icd and Dl1icd, which may be a result
of the eﬃcient interaction of Notch 1 and Delta 1 promoted
by LFng activity.
In the developing Drosophila wing, activation of Notch re-
sults in direct upregulation of cell proliferation without aﬀect-
ing cell fate determination [22]. In hematopoietic cells, the
expression of N1icd results in delays of cell diﬀerentiation
and diminishes the number of cells in the G0/G1 phase of the
cell cycle, which also suggests induction of cell proliferation
[23]. In order for proper Notch signaling to occur, there must
be a distinction between a signaling cell versus a receiving cell.
Based on the observations that Dl1icd induced non-proliferat-
ing phenotype, we suggest that its role in developing organisms
is related to cell synchronization, tissue sculpting, and repair.
In this scenario, at least three hypothetical situations may ex-
ist: (i) when a cell expressing Delta and Notch is surrounded byinhibition of DNA synthesis. HUVEC were transduced with N1icd or
formed. Cells were labeled for 16 h with [3H]-thymidine 36 h after the
nuclei ± S.D. are presented. (B) Dl1icd-induced acidic b-galactosidase
were additionally transduced with either Dl1icd or LacZ. Cells were
1 expression. HUVEC were transduced with N1icd or LacZ; and 16 h
later cell lysates were prepared, resolved by 15% SDS–PAGE, and
protein loading.
5802 V. Kolev et al. / FEBS Letters 579 (2005) 5798–5802similar cells, the signals conducted through ligand and receptor
are balanced and normal tissue homeostasis is maintained; (ii)
when signaling through Notch is downregulated, e.g., by
Numb [24], Delta signaling dominates over Notch signaling
and cells stop proliferating as a result of Delta icd production;
(iii) when Notch activation by Delta from a neighboring cell is
potentiated by Fringe, the balance of signaling through Notch
and Delta is skewed, and cell proliferation is upregulated.
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